| Name | Inspiration Healthcare Group |
|---|---|
| Epic | IHC |
| Isin | GB00BXDZL105 |
| Industry | Chemicals |
| Latest share price | 12.85p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £11.52 | Debt ratio | n/a |
| Shares in issue | 89.66 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | 0.205p | Price to book value | n/a |
| Dividend yield | 0.5 | ROCE | -17.28 |
| Dividend cover | -44.25 | EPS growth | n/a |
| Earning per share | -8.85 | 52-week high / low | 12.50p / 53.50p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Interim | 2023-11-23 | 2023-12-22 | 0.205p |
| Final | 2023-06-29 | 2023-07-28 | 0.41p |
| Interim | 2022-11-24 | 2022-12-28 | 0.205p |
| Final | 2022-06-30 | 2022-07-29 | 0.41p |
| Interim | 2021-11-25 | 2021-12-29 | 0.20p |
| Final | 2021-07-01 | 2021-07-30 | 0.40p |
| Interim | 2020-11-26 | 2020-12-29 | 0.20p |
| Company name | Inspiration Healthcare Group |
|---|---|
| Address | Unit 7/8 Commerce Park, Commerce Way, Croydon, United Kingdom, CR0 4YL |
| Telephone | |
| Website | http://www.inspiration-healthcare.com/# |
| Director | Position |
|---|---|
| Mr Alan Olby | CFO |
| Ms Louise Marie Janssen-Counotte | Non-Executive Director |
| Mr Liz Shanahan | Non-Executive Director |
| Mr Neil Campbell | Non-Executive Director |
| Mr Gordon Roy Davis | Executive Chairman |
| Mr Bob Beveridge | Senior Independent Non-Executive Director |
| Assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Reporting date | 31/01/24 | 31/01/23 | 31/01/22 |
| Intangible asssets and goodwill | 13.28 | 17 | 15.82 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 25.99 | 30.8 | 25.09 |
| Inventory / work in progress | 13.74 | 9.94 | 6.45 |
| Trade and other receivables | 8.67 | 11.89 | 9.31 |
| Cash and equivalents | 0.41 | 2.28 | 9.25 |
| Other current assets and asset held for resale | 0.2 | n/a | n/a |
| Total of all assets | 49.01 | 54.89 | 50.11 |
| Liabilities £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Short term liabilities | 9.57 | 9.24 | 7.72 |
| Long term liabilities | 10.48 | 10.18 | 6.9 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 20.05 | 19.42 | 14.62 |
| Net assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net assets | 28.97 | 35.47 | 35.49 |
| Equity £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Share capital | 6.82 | 6.81 | 6.81 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | 18.84 | 25.58 | 25.73 |
| Share premium account | 18.91 | 18.84 | 18.84 |
| Total equity | 28.97 | 35.47 | 35.49 |
| Income £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -4.93 | 0.43 | 4.25 |
| Pre-tax profit | -5.68 | 0.08 | 3.96 |